retatrutide weight loss efficacy Effects of once-weekly subcutaneous on and metabolic markers: A systematic review and meta-analysis of randomized controlled trials Retatrutide—A Game Changer in Obesity

These side effects are usually mild and temporary, but its important to communicate any concerns with your healthcare provider

This is often the first and only sign of gradual degradation that isn't visually apparent

Clinical data from the STEP 1 trial shows average weight loss of approximately 5.9 percent of baseline body weight at 12 weeks

If youre deciding what to do now: Retatrutide is promising, but its not widely available because its still in clinical trials

Recent clinical trials suggest semaglutide and other medications that mimic GLP-1 may reduce the risk of cardiovascular events like heart attacks and stroke, help treat heart failure, and offer other cardiovascular benefits

ArticlePubMed 4